We're also talking about the latest reason that your health insurance premium is likely to rise in 2019 in the U.S., we'll walk you through “Clinical Trials 101” and explain what each phase of a clinical trial is really all about, and we'll give you the latest update on Ocrevus being rejected as a treatment for PPMS in the U.K.
We have a lot to talk about! Are you ready for RealTalk MS?
U.S. Suspends Payments to Health Insurers 1:47
Everything You Always Wanted To Know About Clinical Trials 8:25
Clinical Trial to Track Urinary Symptoms in MS Is Recruiting Participants 15:05
NICE Rejects Ocrevus for PPMS 16:47
Cannabis & MS 19:04
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com
U.S. Suspends Payments to Health Insurers
National MS Society Brochure on Participating in a Clinical Trial
Sample Urinary Symptoms & MS Clinical Trial Survey
Cannabis Use in People with Parkinson's Disease and Multiple Sclerosis: A Web-Based Investigation
National MS Society Research Paper on Cannabis & MS
AAN Guidelines for Medical Marijuana
Real World Experience of Medical Marijuana in Symptomatic Management of Multiple Sclerosis and Transverse Myelitis
Cannabidiol to Improve Mobility in People with MS
Knowledge and Attitudes of Australian General Practitioners Towards Medicinal Cannabis: A Cross-Sectional Survey
Give RealTalk MS a Rating & Review
Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.
RealTalk MS Episode 43
Hosted By: Jon Strum
Tags: MS, MultipleSclerosis, MSResearch, Ocrevus, ACA, ProtectOurCare, MSActivist, CannabisandMS, Cannabis, RealTalkMS